Τετάρτη 18 Μαρτίου 2020


T-Cell based therapies for overcoming neuroanatomical and immunosuppressive challenges within the glioma microenvironment
Abstract Glioblastoma remains as the most common and aggressive primary adult brain tumor to date. Within the last decade, cancer immunotherapy surfaced as a broadly successful therapeutic approach for a variety of cancers. However, due to the neuroanatomical and immunosuppressive nature of malignant gliomas, conventional chemotherapy and radiotherapy treatments garner limited efficacy in patients with these tumors. The intricate structure of the blood brain barrier restricts...
Neuro-Oncology
Tue Mar 17, 2020 02:00
Diet and Use of Fallback Foods by Rwenzori Black-and-White Colobus ( Colobus angolensis ruwenzorii ) in Rwanda: Implications for Supergroup Formation
Abstract When preferred foods are scarce, one strategy employed by primates is to switch to an alternative food item of lower quality or preferability, i.e., a fallback food. In the montane rainforest of Nyungwe National Park in southwestern Rwanda, Rwenzori black-and-white colobus (Colobus angolensis ruwenzorii) (hereafter Rwenzori colobus) form a supergroup comprising hundreds of individuals. Over 13 mo we investigated how this supergroup uses resources in periods of resource...
International Journal of Primatology
Tue Mar 17, 2020 02:00
miR-331-3p Suppresses Cell Proliferation in TNBC Cells by Downregulating NRP2
Technology in Cancer Research &Treatment, Volume 19, Issue , January-December 2020. Purpose:Triple-negative breast cancer is characterized by fast progression with high possible for metastasis and poor survival. Dysfunction of microRNAs plays an important role in the initiation and progression of cancer. Our previous microRNA-seq data indicated the downregulation of miR-331-3p in triple-negative breast cancer tissues compared with that of the noncancer tissues. However, the function of miR-331-3p...
SAGE Publications Inc: Technology in Cancer Research & Treatment: Table of Contents
Mon Mar 16, 2020 12:58

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Αρχειοθήκη ιστολογίου